Robert Shafer
Robert Shafer
Professor of Medicine, Stanford University
E-mail confirmado em stanford.edu - Página inicial
Título
Citado por
Citado por
Ano
2011 update of the drug resistance mutations in HIV-1
VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, R Shafer, ...
Topics in antiviral medicine 19 (4), 156, 2011
11752011
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ...
PloS one 4 (3), e4724, 2009
9332009
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
International HIV Controllers Study
Science 330 (6010), 1551-1557, 2010
8422010
Human immunodeficiency virus reverse transcriptase and protease sequence database
SY Rhee, MJ Gonzales, R Kantor, BJ Betts, J Ravela, RW Shafer
Nucleic acids research 31 (1), 298-303, 2003
7952003
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection
PM Small, RW Shafer, PC Hopewell, SP Singh, MJ Murphy, E Desmond, ...
New England Journal of Medicine 328 (16), 1137-1144, 1993
7141993
2017 update of the drug resistance mutations in HIV-1
AM Wensing, V Calvez, HF Günthard, VA Johnson, R Paredes, D Pillay, ...
Topics in antiviral medicine 24 (4), 132, 2016
6652016
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.
RW Shafer, LM Smeaton, GK Robbins, SW De Gruttola, Victor, Snyder, ...
New England Journal of Medicine 349 (24), 2304-15, 2003
564*2003
Web resources for HIV type 1 genotypic-resistance test interpretation
TF Liu, RW Shafer
Clinical infectious diseases 42 (11), 1608-1618, 2006
5282006
Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance
C Wang, Y Mitsuya, B Gharizadeh, M Ronaghi, RW Shafer
Genome research 17 (8), 1195-1201, 2007
4952007
HIV-1 drug resistance mutations: an updated framework for the second decade of HAART
RW Shafer, JM Schapiro
AIDS reviews 10 (2), 67, 2008
4112008
Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection
RW Shafer, DS Kim, JP Weiss, JM Quale
Medicine 70 (6), 384-397, 1991
4031991
Genotypic testing for human immunodeficiency virus type 1 drug resistance
RW Shafer
Clinical microbiology reviews 15 (2), 247-277, 2002
3962002
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
RW Shafer, SY Rhee, D Pillay, V Miller, P Sandstrom, JM Schapiro, ...
AIDS (London, England) 21 (2), 215, 2007
3732007
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration
R Kantor, DA Katzenstein, B Efron, AP Carvalho, B Wynhoven, P Cane, ...
PLoS Med 2 (4), e112, 2005
3602005
HIV-1 antiretroviral resistance
MW Tang, RW Shafer
Drugs 72 (9), e1-e25, 2012
3412012
Rationale and uses of a public HIV drug‐resistance database
RW Shafer
The Journal of infectious diseases 194 (Supplement_1), S51-S58, 2006
3152006
Update of the drug resistance mutations in HIV-1: March 2013
VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, RW Shafer, ...
Topics in antiviral medicine 21 (1), 6, 2013
3022013
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.
AK Iversen, RW Shafer, K Wehrly, MA Winters, JI Mullins, B Chesebro, ...
Journal of virology 70 (2), 1086-1090, 1996
3001996
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study
DW Haas, LM Smeaton, RW Shafer, GK Robbins, GD Morse, L Labbé, ...
The Journal of infectious diseases 192 (11), 1931-1942, 2005
2882005
Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade
RW Shafer, BR Edlin
Clinical infectious diseases 22 (4), 683-704, 1996
2731996
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20